An interventional study of Margin shaving in Margin, Tumor-Free, Breast Cancer and Surgery, sponsored by Hospital Universitari de Bellvitge. Recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.
Sponsored by Hospital Universitari de Bellvitge · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The objective of this clinical trial is to demonstrate the reduction of positive margins in the definitive pathology of patients undergoing breast-conserving surgery with the systematic shaving technique compared to conventional surgery, and the reduction of second interventions for margin enlargement.
Patients with breast cancer who undergo breast-conserving surgery are randomized in the operating room after lumpectomy into 2 groups of 117 patients each: shaving/no-shaving (standard surgery).
94 studies on the registry are indexed under Margins of Excision; 38 are open to participants now.
This study's planned enrollment of 234 is above the median of 87 across 65 interventional studies indexed under Margins of Excision.
Browse Margins of Excision studies →Hospital Universitari de Bellvitge is the lead sponsor of 120 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subsequent to lumpectomy, a circumferential enlargement of all lumpectomy margins, including lateral, medial, superior, inferior, anterior, and posterior, approximately 5-10mm thick, will be resected.
Procedure: Margin shaving
Standard lumpectomy
Procedure: Margin shaving
In both cohorts, an intraoperative study of the margins will be carried out, and enlargement of those margins that are affected will be carried out as indicated by the pathologist. Subsequently, shaving is performed in case of being randomized to the study group or surgery is completed in the control group.
Margin involvement
To compare the number of cases with affected margins in the definitive pathological anatomy, of the cases with intraoperative systematic shaving versus the group of no shaving
Time frame: 3 weeks after each surgery
Re-interventions
Demonstrate the reduction of second surgeries to widen affected margins in breast conserving surgery with the shaving technique
Time frame: 3 weeks after each surgery
Shaving versus intraoperative pathological study
Assess the possibility of replacing the intraoperative study of the margins with systematic shaving
Time frame: 3 weeks after each surgery
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2020 (actual). Primary completion is estimated for Jun 2027, 80 months after the start.
Of 28 interventional studies with no phase under Margins of Excision, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 63. This study's planned 80 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Universitari de Bellvitge →